PubMed:28549065
Annnotations
PubMed_ArguminSci
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 116-322 | DRI_Approach | denotes | Activation of the FOXO transcription factor DAF-16 by reduced insulin/IGF signaling (IIS) is considered to be beneficial in C. elegans due to its ability to extend lifespan and to enhance stress resistance. |
T2 | 437-449 | DRI_Background | denotes | In contrast, |
T3 | 468-614 | DRI_Background | denotes | causes a tumorous germline phenotype characterized by hyperproliferation of the germline stem cells and rupture of the adjacent basement membrane. |
T4 | 615-702 | DRI_Outcome | denotes | Here we show that cross-talk between DAF-16 and the transforming growth factor ß (TGFß) |
T5 | 720-831 | DRI_Outcome | denotes | protein (BMP) signaling pathway causes germline hyperplasia and results in disruption of the basement membrane. |
T6 | 832-1020 | DRI_Outcome | denotes | In addition to activating MADM/NRBP/hpo-11 gene alone, DAF-16 also directly interacts with both R-SMAD proteins SMA-2 and SMA-3 in the nucleus to regulate the expression of mTORC1 pathway. |
T7 | 1021-1252 | DRI_Background | denotes | Knocking-down of BMP genes or each of the four target genes in the hypodermis was sufficient to inhibit germline proliferation, indicating a cell-non-autonomously controlled regulation of stem cell proliferation by somatic tissues. |
T8 | 1253-1394 | DRI_Approach | denotes | We propose the existence of two antagonistic DAF-16/FOXO functions, a cell-proliferative somatic and an anti-proliferative germline activity. |
T9 | 1395-1457 | DRI_Background | denotes | Whereas germline hyperplasia under reduced IIS is inhibited by |
T10 | 1482-1625 | DRI_Background | denotes | , activation of somatic DAF-16 in the presence of active IIS promotes germline proliferation and eventually induces tumor-like germline growth. |
T11 | 1626-1800 | DRI_Outcome | denotes | In summary, our results suggest a novel pathway crosstalk of DAF-16 and TGF-ß/BMP that can modulate mTORC1 at the transcriptional level to cause stem-cell hyperproliferation. |
T12 | 1801-1967 | DRI_Challenge | denotes | Such cell-type specific differences may help explaining why human FOXO activity is considered to be tumor-suppressive in most contexts, but may become oncogenic, e.g. |
T13 | 1968-2006 | DRI_Background | denotes | in chronic and acute myeloid leukemia. |
Goldhamster2_Cellosaurus
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-1 | CVCL_S361|Finite_cell_line|Mus musculus | denotes | C |
T2 | 42-43 | CVCL_7027|Cancer_cell_line|Homo sapiens | denotes | ß |
T3 | 104-114 | CVCL_C410|Hybridoma|Mus musculus | denotes | activation |
T4 | 116-126 | CVCL_C410|Hybridoma|Mus musculus | denotes | Activation |
T5 | 240-241 | CVCL_S361|Finite_cell_line|Mus musculus | denotes | C |
T6 | 363-371 | CVCL_C410|Hybridoma|Mus musculus | denotes | activity |
T7 | 475-476 | CVCL_6479|Finite_cell_line|Mus musculus | denotes | a |
T8 | 620-622 | CVCL_5M23|Cancer_cell_line|Mesocricetus auratus | denotes | we |
T9 | 694-695 | CVCL_7027|Cancer_cell_line|Homo sapiens | denotes | ß |
T10 | 703-707 | CVCL_D953|Induced_pluripotent_stem_cell|Homo sapiens | denotes | bone |
T11 | 847-857 | CVCL_C410|Hybridoma|Mus musculus | denotes | activating |
T12 | 872-874 | CVCL_5986|Cancer_cell_line|Homo sapiens | denotes | 11 |
T13 | 944-949 | CVCL_UB67|Induced_pluripotent_stem_cell|Homo sapiens | denotes | SMA-2 |
T14 | 944-949 | CVCL_WB08|Transformed_cell_line|Homo sapiens | denotes | SMA-2 |
T15 | 954-959 | CVCL_UB68|Induced_pluripotent_stem_cell|Homo sapiens | denotes | SMA-3 |
T16 | 954-959 | CVCL_WB09|Transformed_cell_line|Homo sapiens | denotes | SMA-3 |
T17 | 1160-1161 | CVCL_6479|Finite_cell_line|Mus musculus | denotes | a |
T18 | 1253-1255 | CVCL_5M23|Cancer_cell_line|Mesocricetus auratus | denotes | We |
T19 | 1321-1322 | CVCL_6479|Finite_cell_line|Mus musculus | denotes | a |
T20 | 1354-1356 | CVCL_8754|Cancer_cell_line|Homo sapiens | denotes | an |
T21 | 1354-1356 | CVCL_H241|Cancer_cell_line|Homo sapiens | denotes | an |
T22 | 1385-1393 | CVCL_C410|Hybridoma|Mus musculus | denotes | activity |
T23 | 1484-1494 | CVCL_C410|Hybridoma|Mus musculus | denotes | activation |
T24 | 1532-1538 | CVCL_C410|Hybridoma|Mus musculus | denotes | active |
T25 | 1658-1659 | CVCL_6479|Finite_cell_line|Mus musculus | denotes | a |
T26 | 1702-1703 | CVCL_7027|Cancer_cell_line|Homo sapiens | denotes | ß |
T27 | 1837-1840 | CVCL_E773|Transformed_cell_line|Homo sapiens | denotes | may |
T28 | 1872-1880 | CVCL_C410|Hybridoma|Mus musculus | denotes | activity |
T29 | 1941-1944 | CVCL_E773|Transformed_cell_line|Homo sapiens | denotes | may |
GoldHamster
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4 | 11-17 | PR:O16850 | denotes | DAF-16 |
T5 | 18-22 | O16850 | denotes | FOXO |
T6 | 18-22 | PR:Q95V55 | denotes | FOXO |
T8 | 44-47 | PR:000000034 | denotes | BMP |
T9 | 44-47 | P35855 | denotes | BMP |
T7 | 44-47 | CHEBI:60815 | denotes | BMP |
T10 | 48-57 | GO:0023052 | denotes | signaling |
T11 | 77-82 | D009369 | denotes | tumor |
T12 | 77-82 | D009369 | denotes | tumor |
T13 | 83-92 | GO:0009058 | denotes | formation |
T15 | 97-103 | D000076222 | denotes | mTORC1 |
T14 | 97-103 | GO:0031931 | denotes | mTORC1 |
T16 | 134-138 | O16850 | denotes | FOXO |
T17 | 134-138 | PR:Q95V55 | denotes | FOXO |
T18 | 139-152 | GO:0006351 | denotes | transcription |
T19 | 139-159 | GO:0000981 | denotes | transcription factor |
T23 | 160-166 | PR:O16850 | denotes | DAF-16 |
T24 | 178-185 | P51463 | denotes | insulin |
T25 | 178-185 | Q91XI3 | denotes | insulin |
T26 | 178-185 | P01308 | denotes | insulin |
T27 | 178-185 | P01340 | denotes | insulin |
T28 | 178-185 | P07453 | denotes | insulin |
T29 | 178-185 | P68988 | denotes | insulin |
T30 | 178-185 | P21563 | denotes | insulin |
T31 | 178-185 | P68245 | denotes | insulin |
T32 | 178-185 | P68990 | denotes | insulin |
T34 | 178-185 | P09476 | denotes | insulin |
T35 | 178-185 | P69047 | denotes | insulin |
T36 | 178-185 | Q8HXV2 | denotes | insulin |
T37 | 178-185 | P12705 | denotes | insulin |
T38 | 178-185 | P68987 | denotes | insulin |
T40 | 178-185 | Q9NDE7 | denotes | insulin |
T41 | 178-185 | P13190 | denotes | insulin |
T42 | 178-185 | P01321 | denotes | insulin |
T43 | 178-185 | C0HJT9 | denotes | insulin |
T44 | 178-185 | P81423 | denotes | insulin |
T45 | 178-185 | P01327 | denotes | insulin |
T46 | 178-185 | P41522 | denotes | insulin |
T47 | 178-185 | C0HJI1 | denotes | insulin |
T48 | 178-185 | P01336 | denotes | insulin |
T49 | 178-185 | P67974 | denotes | insulin |
T50 | 178-185 | P69046 | denotes | insulin |
T51 | 178-185 | P12704 | denotes | insulin |
T52 | 178-185 | P42633 | denotes | insulin |
T53 | 178-185 | P67968 | denotes | insulin |
T54 | 178-185 | P01334 | denotes | insulin |
T55 | 178-185 | P67973 | denotes | insulin |
T56 | 178-185 | P01328 | denotes | insulin |
T57 | 178-185 | P81881 | denotes | insulin |
T58 | 178-185 | P01330 | denotes | insulin |
T59 | 178-185 | Q9W7R2 | denotes | insulin |
T60 | 178-185 | P09477 | denotes | insulin |
T61 | 178-185 | P01311 | denotes | insulin |
T62 | 178-185 | P01315 | denotes | insulin |
T63 | 178-185 | P06306 | denotes | insulin |
T64 | 178-185 | P01319 | denotes | insulin |
T65 | 178-185 | Q6YK33 | denotes | insulin |
T66 | 178-185 | P67971 | denotes | insulin |
T67 | 178-185 | Q62587 | denotes | insulin |
T68 | 178-185 | P68991 | denotes | insulin |
T69 | 178-185 | P12708 | denotes | insulin |
T70 | 178-185 | P04667 | denotes | insulin |
T72 | 178-185 | P68989 | denotes | insulin |
T73 | 178-185 | P01333 | denotes | insulin |
T74 | 178-185 | PR:000009054 | denotes | insulin |
T75 | 178-185 | P30410 | denotes | insulin |
T76 | 178-185 | P01331 | denotes | insulin |
T77 | 178-185 | P01314 | denotes | insulin |
T78 | 178-185 | P01320 | denotes | insulin |
T79 | 178-185 | P01318 | denotes | insulin |
T80 | 178-185 | P12703 | denotes | insulin |
T81 | 178-185 | C0HJI4 | denotes | insulin |
T82 | 178-185 | P30406 | denotes | insulin |
T83 | 178-185 | C0HJU0 | denotes | insulin |
T84 | 178-185 | P68992 | denotes | insulin |
T85 | 178-185 | P67970 | denotes | insulin |
T86 | 178-185 | P18109 | denotes | insulin |
T87 | 178-185 | Q9TQY7 | denotes | insulin |
T88 | 178-185 | O73727 | denotes | insulin |
T89 | 178-185 | P01329 | denotes | insulin |
T90 | 178-185 | P01324 | denotes | insulin |
T92 | 178-185 | P01335 | denotes | insulin |
T93 | 178-185 | P68243 | denotes | insulin |
T94 | 178-185 | P67972 | denotes | insulin |
T95 | 178-185 | P29335 | denotes | insulin |
T96 | 178-185 | P01342 | denotes | insulin |
T97 | 178-185 | P69048 | denotes | insulin |
T98 | 178-185 | P01313 | denotes | insulin |
T99 | 178-185 | P01316 | denotes | insulin |
T100 | 178-185 | P17715 | denotes | insulin |
T101 | 178-185 | P30407 | denotes | insulin |
T102 | 178-185 | P01339 | denotes | insulin |
T104 | 178-185 | P81025 | denotes | insulin |
T105 | 178-185 | P69045 | denotes | insulin |
T106 | 178-185 | P01317 | denotes | insulin |
T107 | 178-185 | P01310 | denotes | insulin |
T108 | 178-185 | Q98TA8 | denotes | insulin |
T109 | 178-185 | P67969 | denotes | insulin |
T110 | 178-185 | P0C236 | denotes | insulin |
T33 | 178-185 | CHEBI:5931 | denotes | insulin |
T39 | 178-185 | D007328 | denotes | insulin |
T71 | 178-185 | CHEBI:145810 | denotes | insulin |
T91 | 178-185 | D007328 | denotes | insulin |
T103 | 178-185 | GO:0016088 | denotes | insulin |
T111 | 186-189 | P22618 | denotes | IGF |
T112 | 190-199 | GO:0023052 | denotes | signaling |
T113 | 201-204 | PR:000014508 | denotes | IIS |
T114 | 201-204 | Q6XE38 | denotes | IIS |
T115 | 280-288 | UBERON:0000104 | denotes | lifespan |
T119 | 356-362 | PR:O16850 | denotes | DAF-16 |
T120 | 381-390 | CL:0000034 | denotes | stem cell |
T121 | 381-404 | GO:0072089 | denotes | stem cell proliferation |
T123 | 391-404 | UBERON:2000098 | denotes | proliferation |
T124 | 418-423 | D009369 | denotes | tumor |
T125 | 418-423 | D009369 | denotes | tumor |
T129 | 461-467 | PR:O16850 | denotes | DAF-16 |
T130 | 572-579 | D012421 | denotes | rupture |
T131 | 572-579 | D012421 | denotes | rupture |
T133 | 596-613 | UBERON:0005769 | denotes | basement membrane |
T132 | 596-613 | GO:0005604 | denotes | basement membrane |
T140 | 652-658 | PR:O16850 | denotes | DAF-16 |
T141 | 667-693 | D015291 | denotes | transforming growth factor |
T142 | 667-693 | D015291 | denotes | transforming growth factor |
T143 | 680-693 | P08441 | denotes | growth factor |
T144 | 680-693 | P08072 | denotes | growth factor |
T145 | 680-693 | Q776B5 | denotes | growth factor |
T146 | 680-693 | Q6RZT5 | denotes | growth factor |
T147 | 680-693 | Q8V307 | denotes | growth factor |
T148 | 703-707 | UBERON:0001474 | denotes | bone |
T149 | 703-707 | UBERON:0002481 | denotes | bone |
T154 | 720-727 | SO:0000104 | denotes | protein |
T153 | 720-727 | PR:000000001 | denotes | protein |
T151 | 720-727 | CHEBI:36080 | denotes | protein |
T152 | 720-727 | CHEBI:11122 | denotes | protein |
T150 | 720-727 | GO:0003675 | denotes | protein |
T156 | 729-732 | PR:000000034 | denotes | BMP |
T157 | 729-732 | P35855 | denotes | BMP |
T155 | 729-732 | CHEBI:60815 | denotes | BMP |
T158 | 729-751 | GO:0030509 | denotes | BMP) signaling pathway |
T161 | 744-751 | CHEBI:34922 | denotes | pathway |
T162 | 768-779 | D006965 | denotes | hyperplasia |
T163 | 768-779 | D006965 | denotes | hyperplasia |
T165 | 813-830 | UBERON:0005769 | denotes | basement membrane |
T164 | 813-830 | GO:0005604 | denotes | basement membrane |
T169 | 858-862 | PR:O35598 | denotes | MADM |
T170 | 858-862 | PR:Q9Y0Y6 | denotes | MADM |
T171 | 858-862 | PR:000001278 | denotes | MADM |
T172 | 858-862 | PR:000011418 | denotes | MADM |
T173 | 858-862 | PR:O14672 | denotes | MADM |
T174 | 858-862 | PR:P97297 | denotes | MADM |
T175 | 858-862 | PR:Q10743 | denotes | MADM |
T176 | 858-862 | PR:Q99J45 | denotes | MADM |
T177 | 863-867 | PR:000011418 | denotes | NRBP |
T178 | 863-867 | PR:Q9UHY1 | denotes | NRBP |
T179 | 863-867 | PR:Q99J45 | denotes | NRBP |
T180 | 868-871 | PR:P55789 | denotes | hpo |
T181 | 868-871 | PR:Q8T0S6 | denotes | hpo |
T183 | 868-871 | PR:000007940 | denotes | hpo |
T184 | 868-871 | A6YIH8 | denotes | hpo |
T182 | 868-871 | CHEBI:32363 | denotes | hpo |
T185 | 875-879 | SO:0000704 | denotes | gene |
T189 | 887-893 | PR:O16850 | denotes | DAF-16 |
T190 | 928-943 | D051896 | denotes | R-SMAD proteins |
T194 | 944-949 | PR:Q9US26 | denotes | SMA-2 |
T197 | 944-949 | PR:Q04658 | denotes | SMA-2 |
T198 | 944-949 | PR:Q02330 | denotes | SMA-2 |
T193 | 944-949 | CVCL_WB08 | denotes | SMA-2 |
T195 | 944-949 | CVCL_UB67 | denotes | SMA-2 |
T196 | 944-949 | D014897 | denotes | SMA-2 |
T201 | 954-959 | PR:O94261 | denotes | SMA-3 |
T202 | 954-959 | PR:P45896 | denotes | SMA-3 |
T199 | 954-959 | CVCL_UB68 | denotes | SMA-3 |
T203 | 954-959 | CVCL_WB09 | denotes | SMA-3 |
T200 | 954-959 | D014897 | denotes | SMA-3 |
T206 | 967-974 | GO:0005634 | denotes | nucleus |
T205 | 967-974 | UBERON:0000125 | denotes | nucleus |
T204 | 967-974 | CHEBI:33252 | denotes | nucleus |
T207 | 1005-1011 | GO:0031931 | denotes | mTORC1 |
T208 | 1005-1011 | D000076222 | denotes | mTORC1 |
T209 | 1012-1019 | CHEBI:34922 | denotes | pathway |
T211 | 1038-1041 | PR:000000034 | denotes | BMP |
T212 | 1038-1041 | P35855 | denotes | BMP |
T210 | 1038-1041 | CHEBI:60815 | denotes | BMP |
T213 | 1088-1098 | UBERON:0002072 | denotes | hypodermis |
T214 | 1088-1098 | UBERON:0007376 | denotes | hypodermis |
T215 | 1134-1147 | UBERON:2000098 | denotes | proliferation |
T217 | 1195-1232 | GO:0072091 | denotes | regulation of stem cell proliferation |
T218 | 1209-1218 | CL:0000034 | denotes | stem cell |
T221 | 1219-1232 | UBERON:2000098 | denotes | proliferation |
T225 | 1298-1304 | PR:O16850 | denotes | DAF-16 |
T226 | 1305-1309 | O16850 | denotes | FOXO |
T227 | 1305-1309 | PR:Q95V55 | denotes | FOXO |
T228 | 1412-1423 | D006965 | denotes | hyperplasia |
T229 | 1412-1423 | D006965 | denotes | hyperplasia |
T230 | 1438-1441 | PR:000014508 | denotes | IIS |
T231 | 1438-1441 | Q6XE38 | denotes | IIS |
T235 | 1458-1464 | PR:O16850 | denotes | DAF-16 |
T239 | 1506-1512 | PR:O16850 | denotes | DAF-16 |
T240 | 1539-1542 | PR:000014508 | denotes | IIS |
T241 | 1539-1542 | Q6XE38 | denotes | IIS |
T242 | 1561-1574 | UBERON:2000098 | denotes | proliferation |
T243 | 1598-1603 | D009369 | denotes | tumor |
T244 | 1598-1603 | D009369 | denotes | tumor |
T245 | 1666-1673 | CHEBI:34922 | denotes | pathway |
T249 | 1687-1693 | PR:O16850 | denotes | DAF-16 |
T251 | 1704-1707 | PR:000000034 | denotes | BMP |
T252 | 1704-1707 | P35855 | denotes | BMP |
T250 | 1704-1707 | CHEBI:60815 | denotes | BMP |
T253 | 1726-1732 | GO:0031931 | denotes | mTORC1 |
T254 | 1726-1732 | D000076222 | denotes | mTORC1 |
T255 | 1771-1780 | CL:0000034 | denotes | stem-cell |
T256 | 1861-1866 | D006801 | denotes | human |
T257 | 1867-1871 | O16850 | denotes | FOXO |
T258 | 1867-1871 | PR:Q95V55 | denotes | FOXO |
T259 | 1901-1906 | D009369 | denotes | tumor |
T260 | 1901-1906 | D009369 | denotes | tumor |
T261 | 1983-2005 | D015470 | denotes | acute myeloid leukemia |
T262 | 1983-2005 | D015470 | denotes | acute myeloid leukemia |